Position paper on the use of botulinum toxin in cerebral palsy

Archives of Disease in Childhood

Volumn 79, Issue 3, 1998, Pages 271-273

  Carr, L J ^a   Cosgrove, A P ^b   Gringras, P ^c   Neville, B G R ^a  

^a Wolfson Institute   (United Kingdom)

^b MUSGRAVE PARK HOSPITAL   (United Kingdom)

^c Harper House Children's Service   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CEREBRAL PALSY; CLINICAL PRACTICE; DRUG USE; GOOD CLINICAL PRACTICE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0031692751     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.3.271     Document Type: Review

References (21)

1. Neville B. Botulinum toxin in the cerebral palsies. BMJ 1994;309:1526-7.
2. Wall SA, Chait LA, Temlett JA, Perkins B, Hillen G, Becker P. Botulinum A chemodenervation: a new modality in cerebral palsied hands. Br J Plastic Surg 1993;46:703-6.
3. Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin. Preliminary investigation. J Pediatr Orthop 1993;13:489-95.
4. Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14:299-303.
5. Cosgrove AP, Corry I, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96.
6. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, Garcia-Ramirez J, Mino-Arango E. Botulinum toxin in the management of cerebral palsy. Pediatr Neurol 1994;10:284-8.
7. Densilic M, Meh D. Botulinum toxin in the treatment of cerebral palsy. Neuropediatr 1995;26:249-52.
8. Simpson LL. The origin, structure and pharmacologic activity of botulinum toxin. Pharmacol Rev 1981;33:155-88.
9. Jankovic J, Brin MF. Theraputic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
10. Forssberg H, Tedroff KB. Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Dev Med Child Neurol 1997;39:635-40.
11. Marion MH, Sheeny M, Sangala S, Soulayrol S. Dose standardisation of botulinum toxin. J Neurol Neurosurg Psychiatry 1995;59:102-3.
12. Brans JW, de Boer IP, Aramideh M, Ongerboer de Visser BW, Speelman JD. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 1995;242:529-34.
13. Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle and Nerve 1993;16:64-6.
14. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the pediatric evaluation of disability inventory. Phys Ther 1990;70:602-10.
15. Msall ME, DiGuadio K, Rogers BT, LaForest S, Catanzaro NL, Campbell J, et al. The functional independence measure for children (WeeFIM). Conceptual basis and pilot use in children with developmental disabilities. Clin Pediatr (Phila) 1994;33:421-30.
16. Jankovic J, Schwartz KS. Longitudinal experence with botulinum toxin injectons for treatment of blepharospasm and cervical dystonia. Neurology 1993;43:834-6.
17. Karp BI, Cole LG, Cohen LG, Grill S, Lou JS, Hallett M. Long term botulinum toxin treatment of focal hand dystonias. Neurology 1994;44:70-6.
18. Berradelli A, Priori A, Mercuri B. Central effects of botulinum toxin. Evidence to support or to refuse [abstract]. Mov Dis 1995;10:364.
19. Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin A in patients with torticollis. Mov Dis 1994;9:213-17.
20. Duce R. A shot of poison could ease the pain of cerebral palsy. Times, 27 May 1997.
21. Moore AP. Cerebral palsy [letter]. Times, 9 June 1997.